Skip to main content
. 2022 Apr 3;14(4):783. doi: 10.3390/pharmaceutics14040783

Table 1.

Selected independent and dependent variables used to optimize AGN-PLHNPs by the 33-BBD.

Independent Variables Low (−1) Medium (0) High (+1)
F1 = Concentration of PLGA (mg/mL) 7 9 11
F2 = Concentration of PL-90G (mg/mL) 5 7 9
F3 = Concentration of P-188 (%) 0.75 1.00 1.25
Dependent variables Goal
R1 = Particle size (PS; nm) Minimize
R2 = Entrapment efficiency (EE; %) Maximize
R3 = Cumulative drug release (CDR; %) Maximize
HHS Vulnerability Disclosure